Sweety Samal

Dr Sweety Samal is a virologist and animal model expert and currently working as Principal Scientist-II at Translational Health Science and Technology Institute, Faridabad, India for more than 15 years. Dr. Samal obtained her PhD in Virology from the University of Maryland in 2012 (USA) following a Master’s in Veterinary Science (M.V.Sc in Virology & Bacteriology) in 2007 (India). She is the Lead Indian PI of the INDIGO project and Co-PI of ENDFLU and IndCEPI. She has established several live-virus; pseudo-virus-based assays and animal models for viral diseases such as corona, influenza, dengue, JEV and mpox- based viruses.

Her expertise focuses on virus characterization, next-generation vaccine design for enveloped viruses and development of suitable animal model and novel assays for infectious diseases, that will benefit the evaluation of vaccine candidates, anti-viral drug screening and therapeutics. Dr. Samal’s long-standing research interest to carry out innovative scientific research on enveloped viral agents leveraging on the expertise gained from HIV, influenza and paramyxoviruses, thus creating a ' Translational and Systems virology platform'.